Atlas Trials

Green Cross Wellbeing

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Green Cross Wellbeing

RecordFirmDate
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop (NCT06493799)Green Cross Wellbeing2024-07-01
GCWB1176 Evaluates the Effectiveness and Safety of Immune Function (NCT05632341)Green Cross Wellbeing2023-01-17
Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome (NCT05528705)Green Cross Wellbeing2022-09-13
GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health (NCT05544942)Green Cross Wellbeing2022-08-23
Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups. (NCT05532124)Green Cross Wellbeing2021-06-01

Track Green Cross Wellbeing automatically

Every clearance here is in the API, with alerts when new ones post.